RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,778,249 | -4.6% | 4,499,293 | +7.4% | 0.01% | -14.3% |
| Q2 2023 | $78,362,144 | -52.1% | 4,190,489 | -53.0% | 0.01% | 0.0% |
| Q1 2023 | $163,529,336 | +179.8% | 8,911,680 | +201.9% | 0.01% | +16.7% |
| Q4 2022 | $58,453,841 | -32.1% | 2,952,214 | -17.5% | 0.01% | -33.3% |
| Q3 2022 | $86,053,000 | +15.1% | 3,576,625 | -12.7% | 0.01% | +28.6% |
| Q2 2022 | $74,756,000 | +6.8% | 4,096,166 | +28.7% | 0.01% | +16.7% |
| Q1 2022 | $69,988,000 | -15.3% | 3,182,701 | +41.5% | 0.01% | 0.0% |
| Q4 2021 | $82,600,000 | +133.1% | 2,248,833 | +97.1% | 0.01% | +100.0% |
| Q3 2021 | $35,432,000 | – | 1,141,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |